EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Utility of Sperm DNA Fragmentation as a Diagnostic Tool for Male Infertility and Its Predictive Value for Assisted Reproductive Technology Outcomes

Coral Zurera-Egea, Sílvia Mateo, Sergi Novo, Marta Asensio, Montserrat Boada iD, Marta Antich, Sergi Rovira, Zaida Sarrate iD, Joan Blanco iD, Ester Anton iD

International Journal of Molecular Sciences · 30.06.2025 · 26 (13) · 6314

DOI: 10.3390/ijms26136314 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 30.06.2025. Verfasst von Coral Zurera-Egea und 9 weiteren Autor:innen. Beteiligte Einrichtung: Genetics of Male Fertility Group, Unitat de Biologia Cel lular, Departament de Biologia Cel lular, de Fisiologia i d'Immunologia, Universitat Autònom…. Hauptthemen laut MEDLINE: DNA Fragmentation, Infertility, Male, Spermatozoa, Reproductive Techniques, Assisted. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: by Instituto de Salud Carlos III, Ministry of Science and Innovation, Government of Spain, Agència de Gestió d'Ajuts Universitaris i de Recerca (AGAUR), Generalitat de Catalunya, Universitat Autònoma de Barcelona.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Standard semen parameters remain the cornerstone of male infertility evaluation, though they often poorly reflect the likelihood of success in assisted reproductive technology (ART). This study evaluates sperm DNA fragmentation (SDF) as a diagnostic tool for male infertility and predictive biomarker for ART success. Semen samples were collected from 20 fertile donors and 40 infertile patients with abnormal semen parameters. A fraction of each sample was used for SDF assessment via TUNEL assay and flow cytometry, while the remaining portion was processed for conventional semen analysis and ART. Infertile patients exhibited higher SDF levels (32.77 ± 13.61%) compared to donors (22.19 ± 8.37%; p < 0.01), a difference that remained statistically significant across all subgroups stratified by semen parameters. Additionally, significant correlations were obtained between the percentage of SDF and sperm count (r = −0.4036), motility (r = −0.6377), and morphology (r = −0.2783). Regarding ART outcomes, patients with low-quality embryos exhibited higher SDF levels compared to those with high-quality embryos (30.02 ± 12.52% vs. 23.16 ± 8.41%; p = 0.0036). Receiver operating characteristic (ROC) curve analysis revealed an area under the curve (AUC) above 0.7 for the classification of male infertility as well as the assessment of embryo quality. Overall, our results support the utility of SDF as both a diagnostic biomarker for male infertility and a predictive indicator of embryo quality in ART, particularly in the presence of an oocyte-related female factor.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DNA FragmentationInfertility, MaleSpermatozoaReproductive Techniques, AssistedHumansMaleAdultSemen AnalysisFemaleROC CurveSperm Motility

Stichwörter der Autor:innen

SDFblastocyst formationembryo qualityfertilizationimplantationinfertilityseminal alterations

Autor:innen und Institutionen

  • Genetics of Male Fertility Group, Unitat de Biologia Cel lular, Departament de Biologia Cel lular, de Fisiologia i d'Immunologia, Universitat Autònoma de Barcelona, 08193 Cerdanyola del Vallés, Spain.
  • Dexeus Fertility, Department of Obstetrics, Gynecology and Reproductive Medicine, Hospital Universitari Dexeus, 08028 Barcelona, Spain.
  • Fertilab, 08017 Barcelona, Spain.
  • Reproclinic, 08011 Barcelona, Spain.

ORCID-Profile: Montserrat Boada, Zaida Sarrate, Joan Blanco, Ester Anton

Förderung

  • by Instituto de Salud Carlos III, Ministry of Science and Innovation, Government of Spain
  • Agència de Gestió d'Ajuts Universitaris i de Recerca (AGAUR), Generalitat de Catalunya
  • Universitat Autònoma de Barcelona
  • Instituto de Salud Carlos III, Ministry of Science and Innovation, Government of Spain
  • Agència de Gestió d’Ajuts Universitaris i de Recerca (AGAUR), Generalitat de Catalunya
  • UAB

Zitieren

APA

Zurera-Egea, C., Mateo, S., Novo, S., Asensio, M., Boada, M., Antich, M., Rovira, S., Sarrate, Z., Blanco, J., & Anton, E. (2025). The Utility of Sperm DNA Fragmentation as a Diagnostic Tool for Male Infertility and Its Predictive Value for Assisted Reproductive Technology Outcomes. International Journal of Molecular Sciences, 26(13), 6314. https://doi.org/10.3390/ijms26136314

Vancouver

Zurera-Egea C, Mateo S, Novo S, Asensio M, Boada M, Antich M, et al. The Utility of Sperm DNA Fragmentation as a Diagnostic Tool for Male Infertility and Its Predictive Value for Assisted Reproductive Technology Outcomes. International Journal of Molecular Sciences. 2025;26(13):6314. doi:10.3390/ijms26136314

BibTeX
@article{ZureraEgea2025,
  author = {Zurera-Egea, Coral and Mateo, Sílvia and Novo, Sergi and Asensio, Marta and Boada, Montserrat and Antich, Marta and Rovira, Sergi and Sarrate, Zaida and Blanco, Joan and Anton, Ester},
  title = {The Utility of Sperm DNA Fragmentation as a Diagnostic Tool for Male Infertility and Its Predictive Value for Assisted Reproductive Technology Outcomes},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {13},
  pages = {6314},
  doi = {10.3390/ijms26136314}
}
Kostenlos starten →